Tate & Lyle revenue FY2026 rises to US$2.3B as profit Jumps 49%  

UK – Tate & Lyle Plc has reported a 16% rise in revenue to £2.006 billion (US$) for the financial year ended 31 March 2026, compared with £1.74 billion (US$2.02B)) a year earlier, despite continued pressure from weak market demand. 

On an adjusted basis, revenue declined 3%, reflecting the company’s presentation of results as though the acquisition of CP Kelco had been completed at the start of FY2025. 

Adjusted earnings before interest, tax, depreciation and amortisation (EBITDA) rose 3% to £415 million (US$481.35M), supported by cost synergies and productivity gains, which helped offset softer sales performance and ongoing investment in growth initiatives. 

The group reported a 49% increase in pre-tax profit to £131 million (US$151.94M), up from £88 million (US$102.1M) in the previous year. 

However, Tate & Lyle reduced its final dividend by 1.5% to 13.2 pence per share from 13.4 pence, leaving the full-year dividend unchanged at 19.8 pence per share. 

Chief executive Nick Hampton said the year reflected both progress and significant challenges for the business. 

“The year has been one of significant progress and challenge. Progress as shown by the successful completion of the integration of the CP Kelco business with the power of the combination driving increased levels of customer traction and a stronger new business pipeline,” Hampton said. 

He added that market conditions had weighed on performance. 

“Challenge as we simultaneously faced softer market demand than anticipated, an increasingly complex geopolitical landscape and the integration of two large global businesses,” he said, adding that overall financial performance had been disappointing. 

The company said it is taking urgent steps to restore top-line growth, with targeted measures introduced in November showing early progress. 

For the year ending March 2027, Tate & Lyle expects modest revenue growth on a constant currency basis, driven by volume improvements weighted toward the second half of the year. 

It also forecasts broadly flat EBITDA before a US$20 million impact linked to the rescheduling of bio-gums capacity consolidation. 

The outlook assumes limited disruption from geopolitical tensions in the Middle East, while the company continues to implement cost mitigation strategies including procurement efficiencies, operational discipline and pricing actions. 

Earlier this month, Ingredion Inc made a non-binding indicative offer for Tate & Lyle, valuing the company at up to £2.74 billion (US$3.18B), with a deadline of June 11 to declare a firm intention to proceed. 

Sign up HERE to receive our email newsletters with the latest news and insights from Africa and around the world, and follow us on our WhatsApp channel for updates.